Discover a new way to find and share stories you'll loveā€¦ Learn about Reading Desk

Post Profile



Slumdog Clinical Trials contd.

Drug major GlaxoSmithKline (GSK) has unethically tested a breast cancer drug on poor patients in India for approval for new drugs in the Europe Union, said a study. According to an investigation by Mumbai-based Centre for Studies in Ethics and Rights, the firm tested lapatinib on patients flouting Indian Council of Medical Research's (ICMR) ethical guidelines.This trial required seriously ill patients who had not received treatment for their condition.
read more

share

GSK Seeks Approval Of Advanced Breast Cancer Drug For First-Line Treatment

Health : Medical News Today (6 years ago)

GlaxoSmithKline on Wednesday applied for approval to market its breast cancer drug Tykerb in U.S. and Europe as a first-line treatment for women with advanced, hormone-sensitive breast cancer, the AP/Google.com reports. Tykerb, know... Read Post

Promising drug doubled positive effect in hormone-receptor positive breast cancer, study finds

Academics / General Science : Science Daily (2 days ago)

In a groundbreaking study that offers new hope for women with advanced breast cancer, researchers have published final clinical trial results that showed the amount of time patients were on treatment without their cancer worsening (... Read Post

New Study Finds Promising Drug Doubled Positive Effect in Hormone-Receptor Positive Breast Cancer

Health : Newswise Medical News (2 days ago)

In a groundbreaking study that offers new hope for women with advanced breast cancer, researchers from UCLA's Jonsson Comprehensive Cancer Center have published final clinical trial results that showed the amount of time patients we... Read Post


Copyright © 2011 Regator, LLC